Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.2800
-0.0004 (-0.14%)
At close: Aug 21, 2026, 4:00 PM EDT
0.276347
-0.0037 (-1.30%)
After-hours: Aug 21, 2026, 7:49 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $9.92 million as of August 21, 2026. Its market cap has decreased by -90.86% in one year.
Market Cap
9.92M
Enterprise Value
32.60K
1-Year Change
-90.86%
Ranking
Category
Stock Price
$0.28
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $9.92M, a decrease of -97.21%. That is a compound annual growth rate of -78.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.90M | -58.75% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 11.19M |
| Aspire Biopharma Holdings | 11.18M |
| Vistagen Therapeutics | 10.83M |
| Theriva Biologics | 10.78M |
| Lunai Bioworks | 9.77M |
| OSR Health | 9.73M |
| MetaVia | 9.62M |
| FibroBiologics | 9.59M |